ALB and Obesity: In a prospective cohort including 995 CD patients (PANTS study) obesity, smoking, low albumin concentrations, higher baseline markers of disease activity and development of immunogenicity were all associated with low drug concentrations during induction resulting in non-remission at week 54 following anti-TNF therapy.